{"name":"Peng Roc Chen, MD","slug":"peng-roc-chen-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Nicardipine + Verapamil + Nitroglycerin","genericName":"Nicardipine + Verapamil + Nitroglycerin","slug":"nicardipine-verapamil-nitroglycerin","indication":"Hypertension","status":"marketed"}]}],"pipeline":[{"name":"Nicardipine + Verapamil + Nitroglycerin","genericName":"Nicardipine + Verapamil + Nitroglycerin","slug":"nicardipine-verapamil-nitroglycerin","phase":"marketed","mechanism":"This combination reduces cardiac workload and improves coronary blood flow by blocking calcium channels (nicardipine and verapamil) and dilating blood vessels (nitroglycerin).","indications":["Hypertension","Angina pectoris","Coronary artery disease"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTFBtLUZBa3piYnpzS3lyMWtvODZrbGUwMHFNRlJkVjBjXzhlM0pyVnA5UHBsbkVXVjUxOFdsMHFBay13SnU5UUE5VkRWVlMxZkFDa0ZFb0lzVU5QLTNBOUZvdmJ4NG02emFsTXBRMQ?oc=5","date":"2025-12-18","type":"pipeline","source":"American Heart Association Journals","summary":"Trametinib Decreased Intracerebral Hemorrhages and Endothelial-to-Mesenchymal Transition in KRAS - American Heart Association Journals","headline":"Trametinib Decreased Intracerebral Hemorrhages and Endothelial-to-Mesenchymal Transition in KRAS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPcjhiWUk4UWMwMGZoVFp1YVFIRWR6SlJLVjhqYnVCYWY5VkswX05hby1SMTVsRl9vWnFoR3RaZlZudUZCbXVldVN2VnJBUFpYQ3JVeXhBZ1NmMzNZbVAxcldfWXNkS2pCOGFOOFlOWXhiS1FSWmxTSnRLNnByRUdGczZzZS1NNFBsUTh4UVRKY1lyUQ?oc=5","date":"2025-11-05","type":"pipeline","source":"Medical Xpress","summary":"General anesthesia during clot-removal surgery leads to better neurological outcomes at 3 months - Medical Xpress","headline":"General anesthesia during clot-removal surgery leads to better neurological outcomes at 3 months","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE1sVktyaF9sTGJvU0h0bDczWEJPZkRtdnNHTDI5NlpVeG1sbXF6VzFLeGV2STZlbTlBV0JsZWNocnotbnZnN2ZLNjRBWm9RMjlpZTJ5RzU3SFhUaU0?oc=5","date":"2019-01-25","type":"trial","source":"EurekAlert!","summary":"First US patient in novel stem cell trial for stroke disability enrolled at UTHealth - EurekAlert!","headline":"First US patient in novel stem cell trial for stroke disability enrolled at UTHealth - EurekAlert!","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}